Market News Archive

Stay updated with the latest announcements

30 Apr 2026

DACCADYE: Q3 Financials

(Q3 Un-audited): EPS was Tk. (1.24) for January-March 2026 as against Tk. (1.63) for January-March 2025; EPS was Tk. (43.95) for July 2025-March 2026 as against Tk. (3.72) for July 2024-March 2025. NOCFPS was Tk. 0.06 for July 2025-March 2026 as against Tk. 0.40 for July 2024-March 2025. NAV per share was Tk. (18.23) as on March 31, 2026, and Tk. 25.71 as on June 30, 2025.

30 Apr 2026

BENGALWTL: Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.12 for January-March 2026 as against Tk. 0.12 for January-March 2025; EPS was Tk. 0.44 for July 2025-March 2026 as against Tk. 0.42 for July 2024-March 2025. NOCFPS was Tk. 1.31 for July 2025-March 2026 as against Tk. 1.21 for July 2024-March 2025. NAV per share was Tk. 26.32 as on March 31, 2026, and Tk. 26.12 as on June 30, 2025.

30 Apr 2026

SIMTEX: Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.29 for January-March 2026 as against Tk. 0.26 for January-March 2025; EPS was Tk. 0.96 for July 2025-March 2026 as against Tk. 0.87 for July 2024-March 2025. NOCFPS was Tk. 2.67 for July 2025-March 2026 as against Tk. 0.58 for July 2024-March 2025. NAV per share was Tk. 22.39 as on March 31, 2026, and Tk. 22.43 as on June 30, 2025.

30 Apr 2026

ASIATICLAB: Q3 Financials

(Q3 Un-audited): EPS was Tk. 1.39 for January-March 2026 as against Tk. 0.75 for January-March 2025; EPS was Tk. 3.97 for July 2025-March 2026 as against Tk. 1.71 for July 2024-March 2025. NOCFPS was Tk. 5.73 for July 2025-March 2026 as against Tk. 1.73 for July 2024-March 2025. NAV per share with revaluation surplus was Tk. 57.46 as on March 31, 2026, and Tk. 54.08 as on June 30, 2025; NAV per share without revaluation surplus was Tk. 44.25 as on March 31, 2026, and Tk. 40.85 as on June 30, 2025. (cont.)

30 Apr 2026

WALTONHIL: Q3 Financials

(Q3 Un-audited): EPS was Tk. 8.39 for January-March 2026 as against Tk. 11.76 for January-March 2025; EPS was Tk. 19.29 for July 2025-March 2026 as against Tk. 20.90 for July 2024-March 2025. NOCFPS was Tk. 22.32 for July 2025-March 2026 as against Tk. (1.67) for July 2024-March 2025. NAV per share with revaluation was Tk. 366.80 as on March 31, 2026, and Tk. 363.40 as on June 30, 2025; NAV per share without revaluation was Tk. 265.70 as on March 31, 2026, and Tk. 262.08 as on June 30, 2025. (cont.1)

30 Apr 2026

PENINSULA: Q3 Financials

(Q3 Un-audited): EPS was Tk. (0.13) for January-March 2026 as against Tk. (0.01) for January-March 2025; EPS was Tk. (0.09) for July 2025-March 2026 as against Tk. (0.40) for July 2024-March 2025. NOCFPS was Tk. 1.36 for July 2025-March 2026 as against Tk. 0.15 for July 2024-March 2025. NAV per share was Tk. 27.76 as on March 31, 2026, and Tk. 27.90 as on June 30, 2025. Reasons for significant deviation: (cont.1)

30 Apr 2026

RAKCERAMIC: Q1 Financials

(Q1 Un-audited): EPS was BDT (0.13) for January-March 2026 as against BDT (0.06) for January-March 2025. NOCFPS was BDT 0.47 for January-March 2026 as against BDT (0.15) for January-March 2025. NAV per share was BDT 14.89 as on March 31, 2026, and BDT 16.17 as on March 31, 2025. (cont.1)

30 Apr 2026

JAMUNABANK: Q1 Financials

(Q1 Un-audited): Consolidated EPS was Tk. 1.94 for January-March 2026 as against Tk. 1.91 (restated) for January-March 2025. Consolidated NOCFPS was Tk. 24.45 for January-March 2026 as against Tk. 33.31 (restated) for January-March 2025. Consolidated NAV per share was Tk. 28.88 as on March 31, 2026, and Tk. 27.43 as on March 31, 2025.

30 Apr 2026

MONNOAGML: Q3 Financials

(Q3 Un-audited): EPS was Tk. (0.27) for January-March 2026 as against Tk. 0.74 for January-March 2025; EPS was Tk. 0.17 for July 2025-March 2026 as against Tk. 1.76 for July 2024-March 2025. NOCFPS was Tk. 0.03 for July 2025-March 2026 as against Tk. 1.21 for July 2024-March 2025. NAV per share was Tk. 110.68 as on March 31, 2026, and Tk. 110.86 as on June 30, 2025. (cont.1)

30 Apr 2026

ICICL: Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.31 for January-March 2026 as against Tk. 0.22 for January-March 2025. NOCFPS was Tk. (0.46) for January-March 2026 as against Tk. 0.08 for January-March 2025. NAV per share was Tk. 17.68 as on March 31, 2026, and Tk. 17.36 as on December 31, 2025.

30 Apr 2026

UPGDCL: Q3 Financials

(Q3 Un-audited): Consolidated EPS was Tk. 4.69 for January-March 2026 as against Tk. 7.21 for January-March 2025; Consolidated EPS was Tk. 14.69 for July 2025-March 2026 as against Tk. 19.32 for July 2024-March 2025. Consolidated NOCFPS was Tk. 7.22 for July 2025-March 2026 as against Tk. 15.17 for July 2024-March 2025. Consolidated NAV per share was Tk. 82.08 as on March 31, 2026, and Tk. 73.89 as on June 30, 2025. (Cont.)

30 Apr 2026

TECHNODRUG: Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.31 for January-March 2026 as against Tk. 0.33 for January-March 2025; EPS was Tk. 1.18 for July 2025-March 2026 as against Tk. 1.41 for July 2024-March 2025. NOCFPS was Tk. 1.62 for July 2025-March 2026 as against Tk. 0.15 for July 2024-March 2025. NAV per share with revaluation was Tk. 31.38 as on March 31, 2026, and Tk. 30.58 as on June 30, 2025. NAV per share without revaluation was Tk. 27.69 as on March 31, 2026, and Tk. 26.88 as on June 30, 2025. (cont.)

30 Apr 2026

BARKAPOWER: Q3 Financials

(Q3 Un-audited): Consolidated EPS was Tk. 0.76 for January-March 2026 as against Tk. 0.26 for January-March 2025; Consolidated EPS was Tk. 0.87 for July 2025-March 2026 as against Tk. 0.29 for July 2024-March 2025. Consolidated NOCFPS was Tk. (0.40) for July 2025-March 2026 as against Tk. 4.37 for July 2024-March 2025. Consolidated NAV per share was Tk. 23.50 as on March 31, 2026, and Tk. 22.63 as on June 30, 2025. (cont.)

30 Apr 2026

TALLUSPIN: Q3 Financials

(Q3 Un-audited): EPS was Tk. (0.90) for January-March 2026 as against Tk. (0.96) for January-March 2025; EPS was Tk. (1.96) for July 2025-March 2026 as against Tk. (1.43) for July 2024-March 2025. NOCFPS was Tk. 0.008 for July 2025-March 2026 as against Tk. 0.01 for July 2024-March 2025. NAV per share was Tk. 11.38 as on March 31, 2026, and Tk. 13.34 as on June 30, 2025.

30 Apr 2026

MITHUNKNIT: Q3 Financials

(Q3 Un-audited): The Company informed that due to suspension of factory operation, the Earnings Per Share and Net Operating Cash Flow Per share were null. The company has further informed that it is not possible to disclose the Net Asset value (NAV) of the Company before a final report of the enquiry committee recommended by BSEC has been submitted.

30 Apr 2026

RAHIMTEXT: Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.25 for January-March 2026 as against Tk. 0.30 for January-March 2025; EPS was Tk. 2.06 for July 2025-March 2026 as against Tk. 0.80 for July 2024-March 2025. NOCFPS was Tk. 16.02 for July 2025-March 2026 as against Tk. 32.10 for July 2024-March 2025. NAV per share was Tk. 27.60 as on March 31, 2026 and Tk. 25.83 as on June 30, 2025. (cont.)

30 Apr 2026

SQURPHARMA: Q3 Financials

(Q3 Un-audited): Consolidated EPS was Tk. 6.73 for January-March 2026 as against Tk. 6.83 for January-March 2025; Consolidated EPS was Tk. 23.29 for July 2025-March 2026 as against Tk. 21.15 for July 2024-March 2025. Consolidated NOCFPS was Tk. 17.54 for July 2025-March 2026 as against Tk. 11.90 for July 2024-March 2025. Consolidated NAV per share was Tk. 169.79 as on March 31, 2026 and Tk. 157.88 as on June 30, 2025. (cont.)

30 Apr 2026

KBPPWBIL: Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.21 for January-March 2026 as against Tk. 0.08 for January-March 2025; EPS was Tk. 0.57 for July 2025-March 2026 as against Tk. 0.15 for July 2024-March 2025. NOCFPS was Tk. 0.80 for July 2025-March 2026 as against Tk. 0.08 for July 2024-March 2025. NAV per share was Tk. 12.02 as on March 31, 2026 and Tk. 12.07 as on June 30, 2025.

30 Apr 2026

CENTRALPHL: Q3 Financials

(Q3 Un-audited): EPS was Tk. (0.09) for January-March 2026 as against Tk. (0.10) for January-March 2025; EPS was Tk. (0.23) for July 2025-March 2026 as against Tk. (0.24) for July 2024-March 2025. NOCFPS was Tk. (0.01) for July 2025-March 2026 as against Tk. (0.00) for July 2024-March 2025. NAV per share was Tk. 6.64 as on March 31, 2026 and Tk. 6.87 as on June 30, 2025.

30 Apr 2026

AMBEEPHA: Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.40 for January-March 2026 as against Tk. 0.85 for January-March 2025; EPS was Tk. 2.26 for July 2025-March 2026 as against Tk. 2.17 for July 2024-March 2025. NOCFPS was Tk. (22.41) for July 2025-March 2026 as against Tk. (5.69) for July 2024-March 2025. NAV per share was Tk. 14.73 as on March 31, 2026 and Tk. 13.47 as on June 30, 2025.

Latest Price
Workspace
AI Desk
Profile